MEDICLINIC INTERNATIONAL PLC - TR-1: Standard form for notification of major holdings

Release Date: 14/08/2018 13:00
Code(s): MEI
 
Wrap Text
TR-1: Standard form for notification of major holdings

Mediclinic International plc
(Incorporated in England and Wales)
Company Number 8338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60

14 August 2018

TR-1: Standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft
Word format if possible)

1a. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are at-               MEDICLINIC INTERNATIONAL PLC
tached i                                                                           
1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate)
Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an “X”)
An acquisition or disposal of voting rights                     X
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify):

3. Details of person subject to the notification obligation
Name                                                            Coronation Asset Management (Pty) Ltd acting as dis-
                                                                cretionary investment manager on behalf of managed
                                                                portfolios.
City and country of registered office (if applicable)           Cape Town, South Africa

4. Full name of shareholder(s) (if different from 3.)
Name                                                            N/A
City and country of registered office (if applicable)

5. Date on which the threshold was crossed or
reached:                                                        13/08/2018

6. Date on which issuer notified (DD/MM/YYYY):                  13/08/2018

7. Total positions of person(s) subject to the notification obligation
                                                       
                          % of voting rights at-     % of voting rights           Total of both in %         Total number of
                          tached to shares (to-      through financial instru-    (8.A + 8.B)                voting rights of is-
                          tal of 8. A)               ments                                                   suer
                                                     (total of 8.B 1 + 8.B 2)                                                                                                                                                                                                               
Resulting situation
on the date on which
                          3.98%                                                   3.98%                      737 243 810
threshold was
crossed or reached
Position of previous
notification (if          4.92%                                                   4.92%
applicable)


8. Notified details of the resulting situation on the date on which the threshold was crossed or reached
A: Voting rights attached to shares
Class/type of shares              Number of voting rights                             % of voting rights

ISIN code (if possible)           Direct                 Indirect                     Direct                  Indirect
                                  (Art 9 of Directive    (Art 10 of Directive         (Art 9 of Directive     (Art 10 of Directive
                                  2004/109/EC) (DTR5.1)  2004/109/EC)                 2004/109/EC) (DTR5.1)   2004/109/EC)
                                                         (DTR5.2.1)                                           (DTR5.2.1)

GB00B8HX8Z88                      29 352 830                                          3.98%

SUBTOTAL 8. A                                    29 352 830                                             3.98%

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))
                                                                             Number of voting rights
Type of financial in-      Expiration        Exercise/                       that may be acquired if          % of voting rights                                                                                                   
strument                   date              Conversion Period               the instrument is          
                                                                             exercised/converted.

                                             SUBTOTAL 8. B 1

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive
2004/109/EC (DTR5.3.1.1 (b))
                                             Exercise/           Physical or
Type of financial         Expiration         Conversion Pe-      cash                 Number of               % of voting rights                                              
instrument                date               riod                settlement           voting rights
                                                            

                                                                 SUBTOTAL
                                                                 8.B.2

9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an “X”)
Person subject to the notification obligation is not controlled by any natural person or legal entity and
does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) is-
suer
Full chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal en-     X
tity (please add additional rows as necessary)
                                                              % of voting rights
 Name xv                          % of voting rights          through financial         Total of both if it equals or is
                                  if it equals or is          instruments if it         higher than the notifiable 
                                  higher than the             equals or is higher       threshold
                                  notifiable thresh-          than the notifiable           
                                  old                         threshold     
                                                                  
Coronation Fund Managers Ltd
Coronation Investment Man-
agement SA (Pty) Ltd
Coronation Asset Management
(Pty) Ltd                         3.98%                                                 3.98%
 

10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held

11. Additional information
Place of completion          Cape Town, South Africa
Date of completion           13/08/2018

Mediclinic has a primary listing on the Main Market of the LSE in the United Kingdom, with secondary listings on the
JSE in South Africa and the NSX in Namibia.

For further information, please contact:

Company Secretary, Link Company Matters Limited
Jayne Meacham / Caroline Emmet
+44 (0)20 7954 9569
Investor Relations, Mediclinic International plc
James Arnold, Head of Investor Relations
ir@mediclinic.com
+44 (0)20 3786 8181

Media queries
FTI Consulting
Brett Pollard/Debbie Scott – UK
+44 (0)20 3727 1000
Sherryn Schooling – South Africa
+27 (0)21 487 9000

Registered address: 6th Floor, 65 Gresham Street, London, EC2V 7NQ, United Kingdom
Website: www.mediclinic.com
Corporate broker: Morgan Stanley & Co International plc
JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd
Date: 14/08/2018 01:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Email this JSE Sens Item to a Friend.

Share This Story